Institutional Ownership
Eikon Therapeutics Inc
CUSIP 282564103COMQ1 2026
Institutional Holders
48
13F filers
Shares Held
22.61M
Aggregate institutional
Institutional Value
$216.03M
Q1 2026
Net New Holders
+48
48 new · 0 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions48
Increased0
Decreased0
Sold out0
Institutional Holders
48 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Fmr LLC | 3.84M | $40.59M | +3.84M | New |
| 2 | Blackrock, Inc. | 3.32M | $35.12M | +3.32M | New |
| 3 | Foresite Capital Management IV, LLC | 1.94M | $20.56M | +1.94M | New |
| 4 | Merck & Co., Inc. | 1.67M | $17.63M | +1.67M | New |
| 5 | Foresite Capital Management V, LLC | 1.32M | $13.95M | +1.32M | New |
| 6 | Capital World Investors | 1.14M | $12.10M | +1.14M | New |
| 7 | Alliancebernstein L.P. | 1.02M | $10.81M | +1.02M | New |
| 8 | Ecor1 Capital, LLC | 732.6K | $7.75M | +732.6K | New |
| 9 | Baker Bros. Advisors LP | 555.6K | $5.88M | +555.6K | New |
| 10 | Soros Capital Management LLC | 484.7K | $5.13M | +484.7K | New |
38 more institutional holders on Premium
See every fund holding Eikon Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders